This application is directed to inhibitors of dynamin-1-like protein (Drp1) represented by the following structural formula (I): and methods for their use, such as to treat one or more DRP1-related diseases.
本申请涉及以下列结构式(I)为代表的Dynamin-1样蛋白(Drp1)
抑制剂及其使用方法,例如治疗一种或多种DRP1相关疾病。